SUBSCRIBE
SUBSCRIBE
News   Deals

Bristol-Myers Squibb Company Stands by $60 Per Share ImClone Systems Incorporated Offer

September 12, 2008 | 
1 min read
NEW YORK, Sept 11 (Reuters) - Bristol-Myers Squibb Co stood by its $60-a-share offer for ImClone Systems Inc, a day after the biotechnology company spurned Bristol's offer and said it had another bid at $70 a share.
Mergers & acquisitions
Bristol Myers Squibb Company
MORE ON THIS TOPIC
Concept illustration of a businessman hand picking up a star
Mergers & acquisitions
Incyte’s stars align as new CEO strikes $2B Vega takeover for blood disorder asset
June 8, 2026
 · 
2 min read
 · 
Annalee Armstrong
Large yellow signboard on metal frame with the word IPO. Clear sky in the background. Concept of share trading on stock market, capital investment, currency exchange
IPO
Peptide biotech Parabilis targets up to $476M IPO
June 4, 2026
 · 
2 min read
 · 
Gabrielle Masson
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Deals
Regeneron deepens relationship with CytomX, adding up to $2B and eight targets
June 4, 2026
 · 
2 min read
 · 
Tristan Manalac
A train with blue background, 3d rendering. Computer digital drawing.
Artificial intelligence
Alnylam hops on AI train with up to $2B Inceptive partnership
June 4, 2026
 · 
1 min read
 · 
Tristan Manalac